| Dr Evan Joel Davies, DO | |
|
4123 Olympic Blvd Ste 150, Erlanger, KY 41018-3508 | |
| (859) 301-2999 | |
| Not Available |
| Full Name | Dr Evan Joel Davies |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 4123 Olympic Blvd Ste 150, Erlanger, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265412282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 02440 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evan Joel Davies, DO 4123 Olympic Blvd Ste 150, Erlanger, KY 41018-3508 Ph: (859) 301-2999 | Dr Evan Joel Davies, DO 4123 Olympic Blvd Ste 150, Erlanger, KY 41018-3508 Ph: (859) 301-2999 |
News Archive
It's been well established that men perform better than women when it comes to specific spatial tasks. But how much of that is linked to sex hormones versus cultural conditioning and other factors? Researchers at the Norwegian University of Science and Technology (NTNU) decided to explore this idea by administering testosterone to women and testing how they performed in wayfinding tasks in a virtual environment.
Could an over-the-counter health "shot" help fight COVID-19? George Mason University researchers think it just might.
August is National Breastfeeding Awareness Month, and Kaiser Permanente believes that one of the most important choices a mother can make to promote the health of her family is to choose to breastfeed exclusively. Kaiser Permanente, with more than 90,000 births in 2009, uses its integrated care delivery model to help mothers understand the benefits of breastfeeding to both mother and child and support the mother's infant feeding decision.
Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.
Today's headlines reflect state-level health policy developments as well as forward-looking stories related to the cost of federal health reforms.
› Verified 4 days ago
Mrs. Victoria Backscheider, FNP-C Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4123 Olympic Blvd Ste 151, Erlanger, KY 41018 Phone: 859-301-2999 | |
Dr. James David Keller, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4123 Olympic Blvd, Erlanger, KY 41018 Phone: 859-301-2999 Fax: 859-301-2997 | |
Patricia Canfield, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1825 Airport Exchange Blvd, Suite 100, Erlanger, KY 41018 Phone: 615-778-4066 Fax: 615-778-9114 |